These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 11273786

  • 1. Pharmacokinetic population study to describe cefepime lung concentrations.
    Breilh D, Saux MC, Delaisement C, Fratta A, Ducint D, Velly JF, Couraud L.
    Pulm Pharmacol Ther; 2001; 14(2):69-74. PubMed ID: 11273786
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of cefepime in patients with thermal burn injury.
    Bonapace CR, White RL, Friedrich LV, Norcross ED, Bosso JA.
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2848-54. PubMed ID: 10582870
    [Abstract] [Full Text] [Related]

  • 3. Steady-state pharmacokinetics and pharmacodynamics of cefepime administered by prolonged infusion in hospitalised patients.
    Cheatham SC, Shea KM, Healy DP, Humphrey ML, Fleming MR, Wack MF, Smith DW, Sowinski KM, Kays MB.
    Int J Antimicrob Agents; 2011 Jan; 37(1):46-50. PubMed ID: 21074370
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes.
    Ismail M.
    J Vet Pharmacol Ther; 2005 Dec; 28(6):499-503. PubMed ID: 16343281
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
    Whited L, Grove M, Rose D, Rhodes NJ, Scheetz MH, O'Donnell JN, Neeb J, Thoele K, Jones DR, Lowe C, Moore D, Kiel PJ.
    Pharmacotherapy; 2016 Sep; 36(9):1003-10. PubMed ID: 27496678
    [Abstract] [Full Text] [Related]

  • 6. Cefepime in intensive care unit patients: validation of a population pharmacokinetic approach and influence of covariables.
    Georges B, Conil JM, Seguin T, Dieye E, Cougot P, Decun JF, Lavit M, Samii K, Houin G, Saivin S.
    Int J Clin Pharmacol Ther; 2008 Apr; 46(4):157-64. PubMed ID: 18397688
    [Abstract] [Full Text] [Related]

  • 7. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 8. Plasma, urine and skin pharmacokinetics of cefepime in burns patients.
    Sampol E, Jacquet A, Viggiano M, Bernini V, Manelli JC, Lacarelle B, Durand A.
    J Antimicrob Chemother; 2000 Aug; 46(2):315-7. PubMed ID: 10933661
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M, Huitema AD, Meenhorst PL, Schellens JH, Beijnen JH.
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics of cefepime in neonates with severe nosocomial infections.
    Lima-Rogel V, Medina-Rojas EL, Del Carmen Milán-Segovia R, Noyola DE, Nieto-Aguirre K, López-Delarosa A, Romano-Moreno S.
    J Clin Pharm Ther; 2008 Jun; 33(3):295-306. PubMed ID: 18452417
    [Abstract] [Full Text] [Related]

  • 11. Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia.
    Nicasio AM, Ariano RE, Zelenitsky SA, Kim A, Crandon JL, Kuti JL, Nicolau DP.
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1476-81. PubMed ID: 19188394
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of cefepime and comparison with those of ceftiofur in horses.
    Guglick MA, MacAllister CG, Clarke CR, Pollet R, Hague C, Clarke JM.
    Am J Vet Res; 1998 Apr; 59(4):458-63. PubMed ID: 9563631
    [Abstract] [Full Text] [Related]

  • 13. The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion.
    Garrelts JC, Wagner DJ.
    Ann Pharmacother; 1999 Dec; 33(12):1258-61. PubMed ID: 10630824
    [Abstract] [Full Text] [Related]

  • 14. Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers.
    Bächer K, Schaeffer M, Lode H, Nord CE, Borner K, Koeppe P.
    J Antimicrob Chemother; 1992 Sep; 30(3):365-75. PubMed ID: 1452502
    [Abstract] [Full Text] [Related]

  • 15. Acute-phase response alters the disposition kinetics of cefepime following intravenous administration to rabbits.
    Abd El-Aty AM, Goudah A, Mouneir SM, Sunwoo YE, Jang JH, Shin JG, Shim JH, Shimoda M.
    Vet Res Commun; 2007 Jan; 31(1):67-75. PubMed ID: 17186405
    [Abstract] [Full Text] [Related]

  • 16. Mixed pharmacokinetic population study and diffusion model to describe ciprofloxacin lung concentrations.
    Breilh D, Saux MC, Maire P, Vergnaud JM, Jelliffe RW.
    Comput Biol Med; 2001 May; 31(3):147-55. PubMed ID: 11173053
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF, Bulitta J, Lipman J, Kirkpatrick CM.
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [Abstract] [Full Text] [Related]

  • 18. Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients.
    Honoré PH, Joensen SJ, Olsen M, Hansen SH, Mellemgaard A.
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):349-57. PubMed ID: 24934863
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
    Malone RS, Fish DN, Abraham E, Teitelbaum I.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of cefepime in patients with the sepsis syndrome.
    Kieft H, Hoepelman AI, Knupp CA, van Dijk A, Branger JM, Struyvenberg A, Verhoef J.
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():117-22. PubMed ID: 8150754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.